Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Grace Therapeutics, Inc GRCE

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.


NDAQ:GRCE - Post by User

Bullboard Posts
Comment by EternalPonzion Jan 28, 2020 2:46pm
156 Views
Post# 30610082

RE:RE:RE:RE:RE:RE:RE:HERE IS THE AWNSER

RE:RE:RE:RE:RE:RE:RE:HERE IS THE AWNSER
I thought the handle 'EternalPonzi' was rather apt, considering the fact that the only thing that has kept the broader market moving upwards, especially during the last 12 years, is in fact Central Bank 'money printing'. The market as it is currently functioning is a classic Ponzi scheme. The unrestricted printing of any currency is a Ponzi scheme. The only people who escape are those adept enough to convert that currency into something of real value - whatever that might be. This is not to say that there are no suitable and worthy companies that are innovative and have potentially great products. I am of the opinion that the market will eventually pay a price and no amount of money printing will make the typical investor 'rich' enough to combat the accompanying spike in consumer prices. Venezuela is a classic example. Even the great USA will pay the price someday. Its not a matter of if, but when. It won't be sudden either but a slow insidious decline which we are arguably already in. BTW, as much as I hope any company does not go BK, remember this; Whether you buy $100,000 worth of stock and 10 cents per share thinking you got a much better deal than the person would bought $100,000 worth of that same stock at $1 both receive equal pain if the stock goes to zero. Many have learned that lesson the hard way.
Bullboard Posts